Last reviewed · How we verify
ACAMPROSATE CALCIUM
ACAMPROSATE CALCIUM is a drug. It is currently FDA-approved (first approved 2004).
At a glance
| Generic name | ACAMPROSATE CALCIUM |
|---|---|
| Modality | Small molecule |
| Phase | FDA-approved |
| First approval | 2004 |
Approved indications
Common side effects
- Accidental Injury
- Asthenia
- Pain
- Anorexia
- Diarrhea
- Flatulence
- Nausea
- Anxiety
- Depression
- Dizziness
- Dry mouth
- Insomnia
Key clinical trials
- Acamprosate in C9orf72 Hexanucleotide Repeat Expansion Amyotrophic Lateral Sclerosis (ACALS) (PHASE1)
- Temporally-Resolved Electrophysiology of Acamprosate Treatment of Alcohol Use Disorder (PHASE4)
- Integrated Therapies for Alcohol Use in Alcohol-associated Liver Disease (ITAALD) Trial (PHASE2)
- Combining a Smartphone App With Medications to Manage Heavy Drinking (NA)
- Pharmacogenomics and Pharmacometabolomics of Acamprosate Treatment Outcome (PHASE4)
- Acamprosate and Methazolamide for Essential Tremor (PHASE2)
- Safety of Acamprosate in Treating Alcohol Use Disorder in the Post Liver Transplant Populations (PHASE2)
- Investigation of the Efficacy of Acamprosate and Calcium in Comparison to Placebo as Validation of a Behavioural Test for Alcohol Dependence (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| FDA label | Mechanism, indications, dosing, boxed warnings, drug interactions |
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- ACAMPROSATE CALCIUM CI brief — competitive landscape report
- ACAMPROSATE CALCIUM updates RSS · CI watch RSS
Frequently asked questions about ACAMPROSATE CALCIUM
What is ACAMPROSATE CALCIUM?
ACAMPROSATE CALCIUM is a Small molecule drug.
When was ACAMPROSATE CALCIUM approved?
ACAMPROSATE CALCIUM was first approved on 2004.
What development phase is ACAMPROSATE CALCIUM in?
ACAMPROSATE CALCIUM is FDA-approved (marketed).
What are the side effects of ACAMPROSATE CALCIUM?
Common side effects of ACAMPROSATE CALCIUM include Accidental Injury, Asthenia, Pain, Anorexia, Diarrhea, Flatulence.
Related
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing